Ganglion Clinical Trials

22 recruitingLast updated: May 13, 2026

There are 22 actively recruiting ganglion clinical trials across 18 countries. Studies span Not Applicable, Phase 3, Phase 1, Phase 2, Phase 4. Top locations include Toronto, Ontario, Canada, Boston, Massachusetts, United States, Asheville, North Carolina, United States. Updated daily from ClinicalTrials.gov.


Ganglion Trials at a Glance

22 actively recruiting trials for ganglion are listed on ClinicalTrialsFinder across 6 cities in 18 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in Toronto, Boston, and Asheville. Lead sponsors running ganglion studies include Federal Research Institute of Pediatric Hematology, Oncology and Immunology, Children's Oncology Group, and Cairo University.

Browse ganglion trials by phase

Treatments under study

About Ganglion Clinical Trials

Looking for clinical trials for Ganglion? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ganglion trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ganglion clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 22 trials

Recruiting
Phase 3

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

NeuroblastomaGanglioneuroblastoma, Nodular
National Cancer Institute (NCI)478 enrolled177 locationsNCT06172296
Recruiting
Not Applicable

Phase II Study of Proton Radiation Therapy for Neuroblastoma

NeuroblastomaGanglioneuroblastoma
Massachusetts General Hospital30 enrolled1 locationNCT02112617
Recruiting

Project: Every Child for Younger Patients With Cancer

Malignant Solid NeoplasmNeuroendocrine NeoplasmCentral Nervous System Neoplasm+15 more
Children's Oncology Group75,000 enrolled278 locationsNCT02402244
Recruiting
Not Applicable

Sphenopalatine Ganglion Block as Adjuvant to General Anesthesia Regarding the Quality of Surgical Field in Trans-Sphenoidal Endoscopic Hypophysectomy

General AnesthesiaSphenopalatine Ganglion BlockQuality of Surgical Field+1 more
Cairo University70 enrolled1 locationNCT07569952
Recruiting
Phase 2

Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain

MigraineCluster HeadacheCraniofacial Pain+3 more
Stanford University15 enrolled1 locationNCT04930887
Recruiting
Phase 1Phase 2

Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma

High Risk NeuroblastomaRefractory NeuroblastomaRelapsed Neuroblastoma+1 more
Beijing Biotech36 enrolled1 locationNCT07502287
Recruiting
Phase 3

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

NeuroblastomaGanglioneuroblastoma, NodularGanglioneuroblastoma
Children's Oncology Group750 enrolled162 locationsNCT03126916
Recruiting
Phase 3

Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma

Neuroblastoma (NB)Ganglioneuroblastoma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology5 enrolled1 locationNCT07375563
Recruiting
Not Applicable

Ganglion Resection Effectiveness Trial

Connective Tissue DiseaseWrist GanglionGanglion+2 more
Tampere University Hospital220 enrolled4 locationsNCT07162415
Recruiting
Not Applicable

Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Cervicogenic Headache

myofascial trigger pointsCervicogenic headacheDorsal Root Ganglion
Beijing Tiantan Hospital1,036 enrolled1 locationNCT07347730
Recruiting
Not Applicable

tDCS as Treatment for Motor Function

Parkinson DiseaseProgressive Supranuclear PalsyCortical Basal Ganglionic Degeneration
Baycrest20 enrolled1 locationNCT07291687
Recruiting
Phase 4

Percutaneous Blockade of the Stellate Ganglion in Electrical Storm

Ventricular ArrhythmiaStellate Ganglion BlockElectrical Storm
University of Sao Paulo General Hospital64 enrolled1 locationNCT07211347
Recruiting
Not Applicable

Stellate Ganglion Block in Complex Regional Pain Syndrome

Stellate Ganglion Block
Ankara City Hospital Bilkent32 enrolled1 locationNCT07129811
Recruiting
Not Applicable

SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours

NeuroblastomaGanglioneuromaGanglioneuroblastoma
Institut Curie600 enrolled38 locationsNCT05192980
Recruiting
Not Applicable

Effect of Bilateral SPG and Infraorbital Nerve Blocks on Recovery After Septorhinoplasty

Quality of Recovery (QoR-15)Sphenopalatine Ganglion BlockInfraorbital Nerve Block
Konya City Hospital90 enrolled2 locationsNCT06929429
Recruiting
Not Applicable

Sphenopalatine Ganglion Block in Bimaxillary Orthognathic Surgery

Bimaxillar SurgerySphenopalatine Ganglion Block
Bezmialem Vakif University50 enrolled1 locationNCT06933680
Recruiting
Not Applicable

Masseter Muscle Thickness in Gasser Ganglion Radiofrequency Treatment

Trigeminal NeuralgiaGasserian Ganglion; Lesion
Başakşehir Çam & Sakura City Hospital30 enrolled1 locationNCT06278194
Recruiting
Not Applicable

Adding Magnesium Sulfate to Local Anesthetic in Combined Pectoral Nerve and Stellate Ganglion Block for Postoperative Pain Control After Modified Radical Mastectomy

Postoperative PainModified Radical MastectomyMagnesium Sulfate+3 more
Cairo University70 enrolled1 locationNCT06815887
Recruiting
Phase 1

A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.

Post-herpetic neuralgiaPainChronic Pain+4 more
iN Therapeutics Co., Ltd.64 enrolled1 locationNCT06218784
Recruiting

Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification

NeuroblastomaGanglioneuromaGanglioneuroblastoma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology200 enrolled1 locationNCT06296732